Metabolic
0 drugs are in development for Lysosomal Acid Lipase Deficiency.
- Companies
- 0
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Lysosomal Acid Lipase Deficiency pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Lysosomal Acid Lipase Deficiency context
Metabolic·MeSH: Wolman Disease (D015223)
Also known as: Acid Cholesteryl Ester Hydrolase Deficiency, Wolman Type, Acid Lipase Deficiencies, Cholesterol ester hydrolase deficiency, Deficiencies, LAL, Deficiencies, LIPA, Deficiency, Acid Lipase, Deficiency, LAL, Deficiency, LIPA, Disease, Wolman, Disease, Wolman's, Familial Xanthomatoses, Liposomal Acid Lipase Deficiency, Wolman Type, Wolman Disease with Hypolipoproteinemia and Acanthocytosis, Wolman's Xanthomatosis, Xanthomatosis, Familial, Xanthomatosis, Wolman